Active Ingredient History

  • Now
Temoporfin (INN) is a photosensitizer used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck . It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.   Wikipedia

  • SMILES: Oc1cccc(c1)c2c3CCc(n3)c(c4cccc(O)c4)c5ccc([nH]5)c(c6C=Cc([nH]6)c(c7cccc(O)c7)c8ccc2n8)c9cccc(O)c9
  • Mol. Mass: 680.76
  • ALogP: 9.87
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
5,10,15,20-tetra(m-hydroxyphenyl)chlorin | ef9 | foscan | fosgel | foslip | foslipos | meso-tetrahydroxyphenylchlorin | meso-tetra-(hydroxyphenyl)chlorin | meso-tetrahydroxyphenyl chlorin | mthpc | m-thpc | temoporfin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue